Larson Financial Group’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-60
Closed -$274 3474
2025
Q1
$274 Sell
60
-63
-51% -$288 ﹤0.01% 2698
2024
Q4
$694 Buy
123
+72
+141% +$406 ﹤0.01% 2113
2024
Q3
$247 Sell
51
-209
-80% -$1.01K ﹤0.01% 2284
2024
Q2
$1.27K Buy
+260
New +$1.27K ﹤0.01% 1655